These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1201 related articles for article (PubMed ID: 19911968)

  • 1. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
    Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
    Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation.
    Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Kashiwagi S
    J Infect; 2009 Sep; 59(3):207-12. PubMed ID: 19619898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.
    Sugaya N; Tamura D; Yamazaki M; Ichikawa M; Kawakami C; Kawaoka Y; Mitamura K
    Clin Infect Dis; 2008 Aug; 47(3):339-45. PubMed ID: 18582202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.
    Baranovich T; Saito R; Suzuki Y; Zaraket H; Dapat C; Caperig-Dapat I; Oguma T; Shabana II; Saito T; Suzuki H;
    J Clin Virol; 2010 Jan; 47(1):23-8. PubMed ID: 19962344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
    Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
    J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir.
    Matsuzaki Y; Mizuta K; Aoki Y; Suto A; Abiko C; Sanjoh K; Sugawara K; Takashita E; Itagaki T; Katsushima Y; Ujike M; Obuchi M; Odagiri T; Tashiro M
    Virol J; 2010 Mar; 7():53. PubMed ID: 20202225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007.
    Tashiro M; McKimm-Breschkin JL; Saito T; Klimov A; Macken C; Zambon M; Hayden FG;
    Antivir Ther; 2009; 14(6):751-61. PubMed ID: 19812437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid identification of oseltamivir-resistant influenza A(H1N1) viruses with H274Y mutation by RT-PCR/restriction fragment length polymorphism assay.
    Guo L; Garten RJ; Foust AS; Sessions WM; Okomo-Adhiambo M; Gubareva LV; Klimov AI; Xu X
    Antiviral Res; 2009 Apr; 82(1):29-33. PubMed ID: 19428592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic microheterogeneity of emerging H275Y influenza virus A (H1N1) in Toronto, Ontario, Canada from the 2007-2008 respiratory season.
    Eshaghi A; Bolotin S; Burton L; Low DE; Mazzulli T; Drews SJ
    J Clin Virol; 2009 Jun; 45(2):142-5. PubMed ID: 19451021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005/2006.
    Bauer K; Richter M; Wutzler P; Schmidtke M
    Antiviral Res; 2009 Apr; 82(1):34-41. PubMed ID: 19428593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of antiviral agents for the management of severe influenza.
    Smith JR; Ariano RE; Toovey S
    Crit Care Med; 2010 Apr; 38(4 Suppl):e43-51. PubMed ID: 19935416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection.
    Esposito S; Molteni CG; Colombo C; Daleno C; Daccò V; Lackenby A; Principi N
    J Clin Virol; 2010 May; 48(1):62-5. PubMed ID: 20335065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice.
    Ferraris O; Kessler N; Lina B
    Antiviral Res; 2005 Oct; 68(1):43-8. PubMed ID: 16125799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the clinical symptoms and the effectiveness of neuraminidase inhibitors for patients with pandemic influenza H1N1 2009 or seasonal H1N1 influenza in the 2007-2008 and 2008-2009 seasons.
    Kawai N; Ikematsu H; Tanaka O; Matsuura S; Maeda T; Yamauchi S; Hirotsu N; Nishimura M; Iwaki N; Kashiwagi S
    J Infect Chemother; 2011 Jun; 17(3):375-81. PubMed ID: 21120678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(35):969-72. PubMed ID: 19745803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced effectiveness of oseltamivir in children infected with oseltamivir-resistant influenza A (H1N1) viruses with His275Tyr mutation.
    Saito R; Sato I; Suzuki Y; Baranovich T; Matsuda R; Ishitani N; Dapat C; Dapat IC; Zaraket H; Oguma T; Suzuki H
    Pediatr Infect Dis J; 2010 Oct; 29(10):898-904. PubMed ID: 20442686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B.
    Kawai N; Ikematsu H; Iwaki N; Maeda T; Kanazawa H; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Nagai T; Horii S; Hirotsu N; Kashiwagi S
    J Infect; 2008 Jan; 56(1):51-7. PubMed ID: 17936910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.
    Wang B; Dwyer DE; Blyth CC; Soedjono M; Shi H; Kesson A; Ratnamohan M; McPhie K; Cunningham AL; Saksena NK
    Antiviral Res; 2010 Jul; 87(1):16-21. PubMed ID: 20385168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors.
    Escuret V; Frobert E; Bouscambert-Duchamp M; Sabatier M; Grog I; Valette M; Lina B; Morfin F; Ferraris O
    J Clin Virol; 2008 Jan; 41(1):25-8. PubMed ID: 18055253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Naturally occurring oseltamivir resistance in influenza A].
    Madsen L; Nielsen A; Lundgren J
    Ugeskr Laeger; 2010 Aug; 172(32):2165-7. PubMed ID: 20696118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.